AVUV
Avantis U.S. Small Cap Value ETF
SMB
HML
RMW
Adj. R2
0.976
Rel. Sharpe
1.114
Mkt beta
1.06
AUM
US$24.8B
MER
0.25%
Valuation
132
ETF comparison
Verified factor-similar pair
AVUV vs XMVM
These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
HML
RMW
Similarity score
81
Verified similar
The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
Quick Read
- AVUV has the higher backtested relative Sharpe (1.114 vs 0.999).
- AVUV has the lower published fee (0.25% vs 0.41%).
- XMVM is cheaper on dividend valuation (98 vs 132, where 100 is each fund's historical median).
- AVUV has the stronger regression fit (adjusted R-squared 0.976 vs 0.899).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
XMVM
Invesco S&P MidCap Value with Momentum ETF
SMB
HML
RMW
Adj. R2
0.899
Rel. Sharpe
0.999
Mkt beta
0.98
AUM
US$435M
MER
0.41%
Valuation
98
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff +0.44
HML
diff +0.20
RMW
diff +0.02
CMA
diff -0.08
UMD
diff +0.05
Why This Pair Matches
Exposure level
77
Exposure shape
99
Mkt beta diff
0.08
Rel. Sharpe diff
0.115
This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.